BioMarin Announces Second Quarter 2015 Financial Results and Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to BioMarin Announces Second Quarter 2015 Financial Results and Company Update

Wedbush Raises Price Target on BioMarin Pharma (BMRN) to $139 Following 2Q Results

August 5, 2015 6:44 AM EDT

Wedbush reiterated a Neutral rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and raised the price target to $139.00 (from $130.00), following Q2 earnings. Q2 revenues of $250.5MM beat consensus ($218.2MM). GAAP-EPS of $(0.55) was below consensus of $(0.53) due to high Op-Ex.

Analyst Liana Moussatos commented, "Q2... More

Piper Jaffray Raises Price Target on BioMarin Pharma (BMRN) to $168 Following 2Q Results

August 4, 2015 8:41 AM EDT

Piper Jaffray reiterated an Overweight rating on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and raised the price target to $168.00 (from $163.00), following 2Q15 earnings results. Analyst Joshua Schimmer said that the results beat top and bottom line driven primarily by lumpy Naglazyme purchasing and reiterated... More